Dotinurad(CAS NO.: 1285572-51-1)

Product Name: Dotinurad

CAS: 1285572-51-1

MF: C14H9Cl2NO4S

MW: 358.2

Melting point: 188 - 191°C

Boiling point: 614.8±55.0 °C(Predicted)

Density: 1.662±0.06 g/cm3(Predicted)

storage temp.: -20°C Freezer, Under inert atmosphere

Solubility: Chloroform (Slightly, Sonicated), DMSO (Sparingly)

Pka: 4.60±0.25(Predicted)

Form: Solid

Color: White to Off-White

InChI: InChI=1S/C14H9Cl2NO4S/c15-9-5-8(6-10(16)13(9)18)14(19)17-7-22(20,21)12-4-2-1-3-11(12)17/h1-6,18H,7H2

InChIKey: VOFLAIHEELWYGO-UHFFFAOYSA-N

SMILES: C(C1=CC(Cl)=C(O)C(Cl)=C1)(N1C2=CC=CC=C2S(=O)(=O)C1)=O

With the molecular formula C14H9Cl2NO4S and a molecular weight of 358.2, Dotinurad is a solid substance that usually appears white to off-white. It has a melting point range of 188-191 °C, a predicted boiling point of 614.8±55.0 °C, and a density of 1.662±0.06 g/cm3. The importance of Dotinurad in the field of medicine is reflected in its importance for the development of effective treatment options, especially in the provision of non-sedative treatment options. The storage conditions of this compound require storage in a freezer at -20 °C and are carried out in an inert atmosphere to maintain its stability. Dotinurad is not less than 98% pure, suitable for scientific use, and prohibited for human use. In terms of transportation and storage methods, Dotinurad in powder form can be stored for 3 years at -25~-15 °C, and 2 years at 4 °C; If soluble in solvent, it can be stored for 2 years at -85~-65 °C. In summary, Dotinurad, as a urate reabsorption inhibitor, has important application potential in the field of pharmaceutical research, especially in the treatment of hyperuricemia and gout.